Related Experiment Video
Updated: Oct 17, 2025

07:56
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
22.3K
CRISPR-derived genome editing therapies: Progress from bench to bedside.
Holly A Rees1, Alex C Minella1, Cameron A Burnett2
1Beam Therapeutics, Cambridge, MA, USA.
Summary
CRISPR genome editing offers precise DNA manipulation. This review covers its development, cellular mechanisms, therapeutic considerations like off-target edits, and challenges in clinical application for novel therapies.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- CRISPR-derived technologies allow precise DNA sequence editing in the human genome.
- Understanding CRISPR nucleases and DNA base editors is crucial for advancing gene editing applications.
Purpose of the Study:
- To review the development and cellular mechanisms of CRISPR nucleases and DNA base editors.
- To discuss critical factors for translating genome editing tools into therapeutic agents.
- To identify challenges in the clinical application of CRISPR-based therapies.
Main Methods:
- Literature review of CRISPR-derived genome editing technologies.
- Analysis of cellular mechanisms of CRISPR nucleases and DNA base editors.
- Examination of factors influencing therapeutic development and clinical translation.
Main Results:
- CRISPR technologies enable precise DNA manipulation.
- Key considerations for therapeutic development include off-target edits and characterization methods.
- Clinical translation faces challenges in manufacturing, regulation, and trial design.
Conclusions:
- CRISPR genome editing holds significant therapeutic potential.
- Addressing off-target effects and manufacturing/regulatory hurdles is essential for clinical success.
- Further research and development are needed to optimize CRISPR-based therapies for patient use.
Keywords:
Enter keywords hereRelated Concept Videos
CRISPR
53.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.5K
CRISPR/Cas9 Genome Editing
661
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
661
CRISPR and crRNAs
17.8K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.8K
What is Genetic Engineering?
76.1K
Overview
76.1K

